Friedman J A, Piepgras D G, Pichelmann M A, Hansen K K, Brown R D, Wiebers D O
Department of Neurological Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Neurology. 2001 Oct 9;57(7):1212-6. doi: 10.1212/wnl.57.7.1212.
Recent natural history studies have suggested that unruptured intracranial aneurysms smaller than 1 cm have a low risk of rupture. Symptomatic aneurysms may be underrepresented in natural history studies because they are preferentially treated. The authors compared the number of patients with symptoms caused by unruptured intracranial aneurysms smaller than 1 cm treated surgically at their institution with similar patients enrolled in the International Study of Unruptured Intracranial Aneurysms (ISUIA) from their institution over the same time period.
The records of all unruptured aneurysms treated surgically at the Mayo Clinic from 1980 through 1991 were reviewed. There were 97 patients with 117 unruptured aneurysms smaller than 1 cm by angiography. Aneurysms with a history of rupture or larger than 1 cm on cross-sectional imaging were excluded from analysis. The presence and characteristics of symptoms directly attributable to the aneurysm were recorded. Comparison was made with patients from the Mayo Clinic enrolled in the ISUIA retrospective natural history cohort over the same time period.
Of the 97 patients studied, 15 presented with symptoms other than rupture (15.5%). The symptoms were third nerve deficit (seven patients), cerebral ischemia owing to emboli originating from within the aneurysm (five patients), and visual acuity loss (three patients). Eleven other aneurysms had possibly but not definitively caused symptoms; these were considered asymptomatic. No patient from the Mayo Clinic enrolled in the retrospective cohort of the ISUIA had a symptomatic aneurysm smaller than 1 cm on both angiography and cross-sectional imaging.
Unruptured intracranial aneurysms smaller than 1 cm occasionally present with neurologic symptoms. These symptoms are typically owing to mass effect on the second and third cranial nerves or cerebral ischemia as a result of emboli originating from within the aneurysm. Patients with symptomatic unruptured aneurysms less than 1 cm at the Mayo Clinic were preferentially treated. Although existing natural history data may be applied to most unruptured aneurysms, small symptomatic aneurysms may be underrepresented in natural history studies.
近期的自然史研究表明,直径小于1厘米的未破裂颅内动脉瘤破裂风险较低。有症状的动脉瘤在自然史研究中可能未得到充分体现,因为它们会被优先治疗。作者将其机构中因直径小于1厘米的未破裂颅内动脉瘤而出现症状并接受手术治疗的患者数量,与同一时期该机构纳入国际未破裂颅内动脉瘤研究(ISUIA)的类似患者数量进行了比较。
回顾了1980年至1991年在梅奥诊所接受手术治疗的所有未破裂动脉瘤的记录。血管造影显示有97例患者存在117个直径小于1厘米的未破裂动脉瘤。分析排除了有破裂史或在横断面成像中直径大于1厘米的动脉瘤。记录了直接归因于动脉瘤的症状的存在情况和特征。与同一时期纳入ISUIA回顾性自然史队列的梅奥诊所患者进行了比较。
在研究的97例患者中,15例出现了除破裂以外的症状(15.5%)。症状包括动眼神经麻痹(7例患者)、源于动脉瘤内的栓子导致的脑缺血(5例患者)和视力丧失(3例患者)。另外11个动脉瘤可能但未明确导致症状;这些被视为无症状。在ISUIA回顾性队列中,梅奥诊所纳入的患者中,没有在血管造影和横断面成像中均显示有症状且直径小于1厘米的动脉瘤。
直径小于1厘米的未破裂颅内动脉瘤偶尔会出现神经系统症状。这些症状通常是由于对第二和第三脑神经的占位效应或源于动脉瘤内的栓子导致的脑缺血。梅奥诊所中直径小于1厘米且有症状的未破裂动脉瘤患者被优先治疗。尽管现有的自然史数据可能适用于大多数未破裂动脉瘤,但有症状的小动脉瘤在自然史研究中可能未得到充分体现。